The Cardiovascular Impact of COVID-19

The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents the greatest medical challenge in decades. While COVID-19 primarily affects the lungs, causing interstitial pneumonitis and severe acute respiratory distress syndrome (ARDS), it also affects multiple organs, particularly the cardiovascular system. Risk of severe infection and mortality increase with advancing age and male sex. Mortality is increased by comorbidities: cardiovascular disease, hypertension, diabetes, chronic pulmonary disease, and cancer. The most common complications include arrhythmia , cardiac injury, fulminant myocarditis, heart failure, pulmonary embolism, and disseminated intravascular coagulation (DIC).

 

 

  • Cardiac stress test
  • Cardiac ventriculography
  • Positron emission photography
  • Tilt table test
  • Radionucleide angiography
  • Phonocardiogram
  • Computed tomography angiography

Related Conference of The Cardiovascular Impact of COVID-19

August 27-28, 2026

40th European Cardiology Conference

Berlin, Germany
October 20-21, 2026

15th World Heart Congress

London, UK
November 09-10, 2026

7th Annual Summit on Cardiology and Heart Diseases

Paris, France
November 16-17, 2026

8th World Heart Congress

Tokyo, Japan
November 23-24, 2026

40th World Congress on Heart Diseases

Toronto, Canada
November 25-26, 2026

33rd World Heartcare Summit

Paris, France
January 26-27, 2027

12th International Heart Conference

Dubai, UAE
March 18-19, 2027

16th World Heart Congress

Paris, France
May 13-14, 2027

10th Annual Heart Rhythm Conference

Rome, Italy
June 17-18, 2027

10th World Heart and Brain Conference

London, UK
June 21-22, 2027

8th European Summit on Cardiology Research

Zurich, Switzerland

The Cardiovascular Impact of COVID-19 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in